Further study indicated that miR-29 not only directly targets IFN-γ mRNA to control innate and adaptive immune responses to intracellular bacterial infection (45), but also targets T-bet and Eomesodermin (Eomes) (44) to reduce IFN-γ expression, thus limiting Th1 cell differentiation. The gene discussed is IFNG; the disease is bacterial infectious disease.